Oracle founder Larry Ellison said the Stargate project, a joint venture with OpenAI and Softbank, will help to fuel the development of a cancer vaccine.
Billionaire Larry Ellison’s backing of Stargate could help grease the wheels for the embattled merger between Paramount Global and Skydance Media, sources told The Post.
US tech titans Elon Musk, Mark Zuckerberg and Jeff Bezos are taking a prominent place in the new Trump era, but another player from another era -- Oracle boss Larry Ellison -- is making a surprise return.
President Trump unveiled the AI initiative on Tuesday alongside the executives of OpenAI, Oracle and Softbank.
OpenAI has announced that it's teaming up with Softbank and Oracle on $100 billion data center project in the U.S.
Wednesday on the RealClearPolitics podcast, Andrew Walworth, Tom Bevan, and Carl Cannon discussed President Trump introducing "Project Stargate," a new major infrastructure partnership with OpenAI, Oracle,
President Donald Trump announced the $500 billion Stargate Project in Texas to advance AI research, starting with a data center in Abilene.
On Tuesday, OpenAI, SoftBank, Oracle, and MGX announced plans to form Stargate, a new company that will invest $500 billion in AI computing infrastructure across the United States over four years. The announcement came during a White House meeting with President Donald Trump, who called it the "largest AI infrastructure project in history."
The president said he’s also open to another tech giant to acquire TikTok: Larry Ellison, co-founder of Oracle. Ellison was present at the White House for a $500 billion AI infrastructure partnership between the Trump administration and OpenAI, Softbank and Oracle. Oracle, a software company, houses most of TikTok's servers
Oracle Chairman Larry Ellison highlighted AI's potential to revolutionize healthcare with early cancer detection and personalized vaccines. President Donald Trump announced a $500 billion private sector investment in AI infrastructure,
Chairman Larry Ellison highlighted the AI's potential in the development of mRNA-based cancer vaccines. Read more here.